SO-12 Nivolumab (NIVO) plus ipilimumab (IPI) combination therapy in patients with advanced hepatocellular carcinoma (aHCC): 5-year results from CheckMate 040

Authors :: I. Melero
T. Yau
Y. Kang
T. Kim
A. Santoro
B. Sangro
M. Kudo
M. Hou
A. Matilla
F. Tovoli
J. Knox
A. He
B. El-Rayes
M. Acosta-Rivera
H. Lim
S. Soleymani
J. Yao
J. Neely
M. Tschaika
C. Hsu
A. El-Khoueiry
Source :: Annals of Oncology. 33:S361
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools